Document › Details
bioMérieux S.A.. (11/7/16). "Press Release: Pierre Boulud Appointed Corporate Vice President of the Asia Pacific Region at bioMérieux". Marcy l’Étoile.
|Region||Asia & Oceania|
|Organisation||bioMérieux S.A. (Euronext: BIM)|
|Product||in vitro diagnostics (IVD)|
|Person||Mérieux, Alexandre (bioMérieux 201404– CEO before VP Industrial Microbiology)|
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the appointment of Pierre Boulud to the position of Corporate VP in charge of the Asia Pacific region as of November 2. He joins the Executive Committee of bioMérieux and will report directly to Alexandre Mérieux, CEO.
Pierre Boulud will also be in charge of bioMérieux’s portfolio and strategic planning starting on January 1, 2017.
Before joining bioMérieux, Pierre Boulud worked for 14 years at Ipsen pharmaceutical company, where he held various positions, in particular as the head of the Department of Strategy and Business Development. Since 2013, he was Executive Vice President in charge of Specialty Care Commercial Operations. Before he joined Ipsen, he worked at the Boston Consulting Group where he was in charge of strategic consulting assignments for five years. Pierre Boulud began his career in 1995 at the consulting firm Bossard Consultants.
Representing 17% of bioMérieux’s total sales for the first nine months of 2016, with 12.2% year-on-year sales growth, the Asia Pacific region is a major driver of development for the Company.
Pierre Boulud holds a Master of Business Administration from ESSEC.
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2015, bioMérieux’s revenues reached €1,965 million with 90% of international sales.
bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
(Symbol: BIM/Reuters: BIOX.PA/Bloomberg: BIM.FP – ISIN: FR0010096479).
Corporate website: www.biomerieux.com
Investor website: www.biomerieux-finance.com
Tel: + 33 4 78 87 22 37
Tel: + 33 4 78 87 54 75
Laurence Heilbronn Claire Doligez
Tel: + 33 1 53 70 74 64 Tel: + 33 1 53 70 74 48
Record changed: 2016-12-23
More documents for Mérieux (Group)
-  bioMérieux S.A.. (3/3/17). "Press Release: 2016 Financial Results"....
-  bioMérieux S.A.. (2/24/17). "Press Release: bioMérieux’s VIDAS B•R•A•H•M•S PCT Becomes the First FDA-cleared Procalcitonin Assay as an Aid for Antibiotic Stewardship in Respiratory Infections and Sepsis"....
-  bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile....
-  bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA....
-  bioMérieux S.A.. (11/14/16). "Press Release: Business Review for the Nine Months Ended September 30, 2016". Marcy l’Étoile....
-  bioMérieux S.A.. (11/10/16). "Press Release: bioMérieux Launches eMAG, a New Generation Automated System for the Extraction of DNA and RNA". Marcy l’Étoile....
-  bioMérieux S.A.. (10/17/16). "Press Release: Lyme Disease Diagnostic Tests". Marcy l’Étoile....
-  bioMérieux S.A.. (10/11/16). "Press Release: FilmArray Respiratory Panel EZ is CLIA Waived by the FDA". Marcy l’Étoile....
-  bioMérieux S.A.. (10/10/16). "Press Release: BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi Join Forces against Sepsis"....
-  bioMérieux S.A.. (8/31/16). "Press Release: bioMérieux – First-Half 2016 Results". Marcy l’Étoile....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to email@example.com and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]